Premature ventricular contractions and non-sustained ventricular tachycardia:Association with sudden cardiac death, risk stratification, and management strategies

Indian Pacing and Electrophysiology Journal

Volumn 10, Issue 8, 2010, Pages 357-371

  Sheldon, Seth H ^a   Gard, Joseph J ^a   Asirvatham, Samuel J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Ablation; Premature ventricular contractions; PVC; Sudden death; Ventricular tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOFETILIDE; SOTALOL;

ARTICLE; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; DEPOLARIZATION; ECTOPIA CORDIS; HEART ARRHYTHMIA; HEART AUTOMATICITY; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PALPITATION; HEART REPOLARIZATION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PERFORATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LIFESTYLE MODIFICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POLYMORPHIC VENTRICULAR TACHYCARDIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PURKINJE FIBER; QRS COMPLEX; QT INTERVAL; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SYNCOPE; THORAX PAIN; THROMBOEMBOLISM;

EID: 78751507443     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Association AH: Heart Disease and Stroke Statistics - 2010 Update. Dallas, Texas, 2010.
2. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119:1187-1197.
3. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D: Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 2004; 110:522-527.
4. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549-556.
5. Bernard S, Gray T, Buist M, Jones B, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-563.
6. Brodsky M, Wu D, Denes P, Kanakis C, Rosen KM: Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977; 39:390-395.
7. Morshedi-Meibodi A, Evans JC, Levy D, Larson MG, Vasan RS: Clinical correlates and prognostic significance of exercise-induced ventricular premature beats in the community: the Framingham Heart Study. Circulation 2004; 109:2417-2422.
8. Bikkina M, Larson MG, Levy D: Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med 1992; 117:990-996.
9. Abdalla IS, Prineas RJ, Neaton JD, Jacobs DR, Jr., Crow RS: Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men. Am J Cardiol 1987; 60:1036-1042.
10. Chugh SS, Shen WK, Luria DM, Smith HC: First evidence of premature ventricular complexinduced cardiomyopathy: a potentially reversible cause of heart failure. J Cardiovasc Electrophysiol 2000; 11:328-329.
11. Efremidis M, Letsas KP, Sideris A, Kardaras F: Reversal of premature ventricular complexinduced cardiomyopathy following successful radiofrequency catheter ablation. Europace 2008; 10:769-770.
12. Tikkanen JT, Anttonen O, Junttila MJ, Aro AL, Kerola T, Rissanen HA, Reunanen A, Huikuri HV: Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009; 361:2529-2537.
13. Myerburg RJ: Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001; 12:369-381.
14. Myerburg RJ, Interian A, Jr., Mitrani RM, Kessler KM, Castellanos A: Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997; 80:10F-19F.
15. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337:1576-1583.
16. DeBacker G, Jacobs D, Prineas R, Crow R, Vilandre J, Kennedy H, Blackburn H: Ventricular premature contractions: a randomized non-drug intervention trial in normal men. Circulation 1979; 59:762-769.
17. Myers MG: Caffeine and cardiac arrhythmias. Ann Intern Med 1991; 114:147-150.
18. Yusuf S, Wittes J, Friedman L: Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988; 260:2088-2093.
19. Heidenreich PA, Lee TT, Massie BM: Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30:27-34.
20. Pitzalis MV, Mastropasqua F, Massari F, Totaro P, Di Maggio M, Rizzon P: Holter-guided identification of premature ventricular contractions susceptible to suppression by beta-blockers. Am Heart J 1996; 131:508-515.
21. Krittayaphong R, Bhuripanyo K, Punlee K, Kangkagate C, Chaithiraphan S: Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebocontrolled study. Am Heart J 2002; 144:e10.
22. De Ponti R, Ho SY: Mapping of right ventricular outflow tract tachycardia/ectopies: activation mapping versus pace mapping. Heart Rhythm 2008; 5:345-347.
23. Darrieux FC, Scanavacca MI, Hachul DT, Melo SL, D'Avilla AB, Gruppi CJ, Moffa PJ, Sosa EA: Radiofrequency catheter ablation of premature ventricular contractions originating in the right ventricular outflow tract. Arq Bras Cardiol 2007; 88:265-272.
24. Mason JW: A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med 1993; 329:445-451.
25. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989; 321:406-412.
26. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. 1997; 350:1417-1424.
27. Boriani G, Lubinski A, Capucci A, Niederle R, Kornacewicz-Jack Z, Wnuk-Wojnar AM, Borggrefe M, Brachmann J, Biffi M, Butrous GS: A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J 2001; 22:2180-2191.
28. Bashir Y, Thomsen PE, Kingma JH, Moller M, Wong C, Cobbe SM, Jordaens L, Campbell RW, Rasmussen HS, Camm AJ: Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group. Am J Cardiol 1995; 76:1040-1044.
29. Moller M, Torp-Pedersen CT, Kober L: Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Congest Heart Fail 2001; 7:146-150.
30. Tabatabaei N, Asirvatham SJ: Supravalvular arrhythmia: identifying and ablating the substrate. Circ Arrhythm Electrophysiol 2009; 2:316-326.
31. Asirvatham SJ: Correlative anatomy for the invasive electrophysiologist: outflow tract and supravalvar arrhythmia. J Cardiovasc Electrophysiol 2009; 20:955-968.
32. Liu XK, Barrett R, Packer DL, Asirvatham SJ: Successful management of recurrent ventricular tachycardia by electrical isolation of anterolateral papillary muscle. Heart Rhythm 2008; 5:479-482.
33. Francis J, Venugopal K, Khadar SA, Sudhayakumar N, Gupta AK: Idiopathic fascicular ventricular tachycardia. Indian Pacing Electrophysiol J 2004; 4:98-103.
34. Suleiman M, Asirvatham SJ: Ablation above the semilunar valves: when, why, and how? Part I. Heart Rhythm 2008; 5:1485-1492.
35. Suleiman M, Asirvatham SJ: Ablation above the semilunar valves: when, why, and how? Part II. Heart Rhythm 2008; 5:1625-1630.
36. Bogun F, Crawford T, Reich S, Koelling TM, Armstrong W, Good E, Jongnarangsin K, Marine JE, Chugh A, Pelosi F, Oral H, Morady F: Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm 2007; 4:863-867.
37. Asirvatham SJ, Bruce CJ, Friedman PA: Advances in imaging for cardiac electrophysiology. Coron Artery Dis 2003; 14:3-13.
38. Hachiya H, Aonuma K, Yamauchi Y, Harada T, Igawa M, Nogami A, Iesaka Y, Hiroe M, Marumo F: Electrocardiographic characteristics of left ventricular outflow tract tachycardia. Pacing Clin Electrophysiol 2000; 23:1930-1934.
39. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71:215-218.